The findings confirm other studies that show differences in the practice patterns between male and female physicians.
All things being equal, if you’re older and in the hospital, your odds improve if your doctor is a woman.
That’s what a study of more than 1.5 million Medicare claims has found, according to results published Monday in JAMA Internal Medicine. The study, which involved older patients—the average age was 80.2 years—found that those treated by female doctors had lower 30-day mortality rates and lower 30-day readmission rates, both key metrics as Medicare moves toward basing more reimbursement on quality measures.
While the mortality differences were modest, they were still meaningful, and they build on other evidence that is clinically important, say the authors from Harvard’s T.H. Chan School of Public Health and Massachusetts General Hospital. The claims covered January 2011 to December 2014.
“Taken together with previous evidence suggesting that male and female physicians may practice differently, our findings indicate that potential differences in practice patterns between male and female physicians may have important clinical implications for patient outcomes,” they wrote.
Female internists had lower mortality and readmission rates than their male counterparts across a host of conditions, and after adjusting for several physician factors. Besides the lower overall adjusted rate of 30-day mortality (11.07% for women versus 11.49% for men), and a lower adjusted 30-day readmission rate (15.02% vs 15.57%), female physicians had lower mortality rates for sepsis (23.05% versus 25.09%), pneumonia (10.11% versus 11.03%), acute renal failure (12.54% versus 13.30%) and arrhythmia (5.08% versus 6.02%). Other conditions where women physicians recorded lower mortality rates, though not statistically significant ones, included congestive heart failure and urinary tract infections.
The study’s look at older Medicare patients, a fast-growing population, was also important. “Given that there are more than 10 million Medicare hospitalizations due to medical conditions in the United States annually and assuming that the association between sex and mortality is causal, we estimate that approximately 32,000 fewer patients would die if male physicians could achieve the same outcomes as female physicians every year,” the authors wrote.
Researchers took pains to tease out whether the findings could be pinned on male doctors taking care of sicker patients, including one step that weeded out medical intensive care units, as male internists are more likely to work here. Because the study was limited to hospitalists—who specialize in treating admitted patients—the researchers found a population where patients had less ability to select their physician.
“We found that nearly all observable characteristics typically associated with illness severity were well balanced between the male and female physicians,” they wrote. “Even for hospitalist physicians, among whom patients are plausibly more likely to be randomly assigned, we found that patient characteristics were balanced between male and female physicians, and that patients of female physicians continued to have lower patient mortality and readmission rates.”
What’s more important, the researchers write, is why the female physicians produced better results. Other studies suggest women may be more likely to practice evidence-based care, and they may be more deliberate in solving complex cases. In this study, women were more likely to have osteopathic training, and they treated fewer patients in the hospital per year.
“Understanding exactly why these differences in care quality and practice patterns exist may provide valuable insights into improving quality of care for all patients, irrespective of who provides their care,” they wrote.
Reference
Tsugawa Y, Jena AB, Figueroa JF, et al. Comparison of hospital mortality and readmission rates for Medicare patients treated by male vs female physicians [published online December 19, 2016]. JAMA Intern Med. doi: 10.1001/jamainternmed.2016.7875.
The Impact of Nurse Practitioner Attribution in Medicare Shared Savings ACOs
December 5th 2023Allowing nurse practitioners to serve as attribution-eligible providers for Medicare Shared Savings Program accountable care organizations leads to no change in hierarchical condition category risk scores and modest growth in attributed beneficiaries.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
HMO and EPO Insurance Plans More Likely to Promote Use of Biosimilars
November 21st 2023Health plan type highly influences the likelihood of biosimilar uptake, with low-flexibility insurance plans more likely to have patients who either switched to a biosimilar or were initiated on a biosimilar.
Read More
What We’re Reading: UnitedHealth Lawsuit; Fentanyl Crackdown; Global Heat Deaths Increase
November 15th 2023A class action lawsuit was filed against UnitedHealth Group and a subsidiary for allegedly using an algorithm to deny rehabilitation coverage for seriously ill patients; US and China officials are finalizing an agreement to crack down on fentanyl; a study published Tuesday projected global heat deaths to increase by 370% if no action is taken against global warming.
Read More